Prot #RXDX-101-02 / GO40782: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements

Project: Research project

Project Details

StatusActive
Effective start/end date7/11/167/11/22

Funding

  • Quintiles, Inc. (Prot #RXDX-101-02 / GO40782)
  • Ignyta, Inc. (Prot #RXDX-101-02 / GO40782)